LifeMD (NASDAQ:LFMD) Earns “Buy” Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of LifeMD (NASDAQ:LFMD – Free Report) in a research report report published on Monday morning,Benzinga reports. HC Wainwright currently has a $12.00 price target on the stock. A number of other equities analysts also recently commented on LFMD. B. Riley assumed coverage on LifeMD in a research […]
More Stories
WisdomTree China ex-State-Owned Enterprises Fund (NASDAQ:CXSE) Short Interest Update
WisdomTree China ex-State-Owned Enterprises Fund (NASDAQ:CXSE – Get Free Report) was the target of a significant drop in short interest...
Taysha Gene Therapies’ (TSHA) Buy Rating Reiterated at Chardan Capital
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Chardan Capital...
Allogene Therapeutics (NASDAQ:ALLO) Given Outperform Rating at William Blair
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at William Blair in...
Koppers Holdings Inc. (NYSE:KOP) CEO M Leroy Ball Sells 5,000 Shares
Koppers Holdings Inc. (NYSE:KOP – Get Free Report) CEO M Leroy Ball sold 5,000 shares of the firm’s stock in...
Pediatrix Medical Group, Inc. (NYSE:MD) Director Sells $423,660.00 in Stock
Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) Director Mark S. Ordan sold 27,600 shares of the company’s stock...
WK Kellogg Co (NYSE:KLG) Director Purchases $1,154,400.00 in Stock
WK Kellogg Co (NYSE:KLG – Get Free Report) Director G Zachary Gund bought 65,000 shares of the stock in a...